175 related articles for article (PubMed ID: 1681128)
1. [The significance of CA-50, SLX and ST-439 in lung cancer].
Hayasaka S; Takada M; Shinohara T; Imamura S; Takifuji N; Kudoh S; Matsui K; Kusunoki Y; Masuda N; Negoro S
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Jul; 29(7):802-7. PubMed ID: 1681128
[TBL] [Abstract][Full Text] [Related]
2. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of tumor-associated glycosylated antigen, sialylated Lewis].
Hiratani K
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1096-103. PubMed ID: 1684396
[TBL] [Abstract][Full Text] [Related]
4. [Determination of various tumor markers, with special reference to sialyl SSEA-1 antigen in lung cancer].
Satoh H; Yano H; Naitoh T; Takahashi N; Suyama T; Murayama J; Kameyama M; Fukuda K; Satoh T; Ohtsuka M
Gan To Kagaku Ryoho; 1988 Oct; 15(10):2917-22. PubMed ID: 2902833
[TBL] [Abstract][Full Text] [Related]
5. [Tumor markers. I. Their significance in the preoperative assessment of lung neoplasms].
Ratto GB; Capponi G; De Grandi R; Augeri C; Secco GB; Fardelli R
Minerva Chir; 1990 Oct; 45(20):1265-72. PubMed ID: 1964495
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of carcinoembryonic antigen, squamous cell carcinoma antigen, CA 125, and CA 50 cytosolic content in non-small cell lung cancer.
Picardo AL; Torres AJ; Maestro M; Ortega D; Garcia-Asenjo JA; Mugüerza JM; Hernando F; Diez M; Balibrea JL
Cancer; 1994 May; 73(9):2305-11. PubMed ID: 8168034
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of serum CA130 in patients with lung cancer].
Matsubara Y; Shiota T; Ishida H; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T; Ikeda S
Nihon Gan Chiryo Gakkai Shi; 1989 Aug; 24(8):1557-65. PubMed ID: 2572655
[TBL] [Abstract][Full Text] [Related]
8. [A clinical study on CA 15-3, CEA, SCC-Ag in patients with squamous cell carcinoma of the lung].
Moriya H; Suzuki S; Aizumi J; Kimura K; Urabe S; Higuci Y; Hoshi K
Rinsho Hoshasen; 1989 Jan; 34(1):63-6. PubMed ID: 2724610
[TBL] [Abstract][Full Text] [Related]
9. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
[TBL] [Abstract][Full Text] [Related]
10. [Study of CEA as a marker of cancer and its surrounding tissue in 145 cases of lung carcinoma].
Jia XS
Zhonghua Bing Li Xue Za Zhi; 1988 Sep; 17(3):173-5. PubMed ID: 2852548
[No Abstract] [Full Text] [Related]
11. [Ca 19-9 and Ca 50 in the diagnosis of bronchial carcinoma: comparison with CEA].
Pecchio F; Rapellino M; Oliaro A; Moscato D; Adamo R; Albertino B; Lo Faso C; Faga C; Borasio P
Minerva Med; 1988 Mar; 79(3):183-6. PubMed ID: 2834670
[TBL] [Abstract][Full Text] [Related]
12. [Clinical usefulness of the combination assay of CA 125, SLX, and CA 72-4 in patients with ovarian cancer].
Kobayashi H; Kawashima Y
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1731-5. PubMed ID: 2574209
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of CEA levels in lung cancer].
Noge S; Hara N; Ichinose Y; Ishimatsu T; Motohiro A; Etoh K; Miyake J; Ohta M
Gan No Rinsho; 1985 May; 31(6 Suppl):616-22. PubMed ID: 2993691
[TBL] [Abstract][Full Text] [Related]
14. [Usefulness and limitation of serum tumor markers in diagnosis of lung cancer].
Fukuda M; Oka M
Nihon Rinsho; 1996 Jun; 54(6):1610-5. PubMed ID: 8691617
[TBL] [Abstract][Full Text] [Related]
15. Squamous cell carcinoma antigen as an adjunct tumour marker in primary carcinoma of the lung.
Cheah PL; Liam CK; Yap SF; Looi LM
J Clin Pathol; 1994 Jun; 47(6):535-7. PubMed ID: 8063936
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of serum tumor markers in patients with lung cancer.
Hatzakis KD; Froudarakis ME; Bouros D; Tzanakis N; Karkavitsas N; Siafakas NM
Respiration; 2002; 69(1):25-9. PubMed ID: 11844959
[TBL] [Abstract][Full Text] [Related]
17. [Sialyl Lewis X-i (SLX) in the bronchoalveolar lavage fluid from patients with lung cancer].
Shimizu S; Suzuki H; Noguchi E
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 May; 30(5):815-20. PubMed ID: 1352835
[TBL] [Abstract][Full Text] [Related]
18. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K
Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864
[TBL] [Abstract][Full Text] [Related]
19. [Clinical significance of serum NCC-ST 439 as a tumor marker for colorectal cancer].
Yamaguchi A; Kurosaka Y; Ohta N; Kamata T; Ishida T; Nishimura G; Katoh M; Kosaka T; Yonemura Y; Miyazaki I
Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2645-50. PubMed ID: 2549882
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of sialyl SSEA-1 antigen in patients with lung cancer].
Shiota T; Matsubara Y; Ikeda S; Ishida H; Katsura A; Hanawa T; Yagi K; Kosaba S; Hatakenaka R; Funatsu T
Nihon Gan Chiryo Gakkai Shi; 1989 May; 24(5):1067-73. PubMed ID: 2570808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
